Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (71-80 of 372) with videos related to

Pageof 38
Sort By:
Gut|August 8, 2013
Treatment of patients with dual hepatitis B and C: a step in the right directionAlessio Aghemo, Massimo Colombo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2013
Safety of direct antiviral agents in real lifeRoberta D'Ambrosio, Massimo Colombo
Seminars in Immunopathology|September 27, 2012
Hepatocellular carcinoma in chronic hepatitis C: from bench to bedsideAlessio Aghemo, Massimo Colombo
Hepatic Oncology|October 11, 2018
The impact of antiviral therapy on hepatocellular carcinoma epidemiologyMassimo Colombo, Ana Lleo
Seminars in Liver Disease|March 5, 2013
Shaping the future management of hepatocellular carcinomaGhassan Abou-Alfa, Massimo Colombo
Gastroenterology|May 29, 2014
Bacterial translocation and nonselective β-blockers in portal hypertension: where we are, what we still needVincenzo La Mura, Massimo Colombo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2014
Entering a new era in the treatment of hepatitis CMassimo Colombo, Markus Peck-Radosavljevic
Expert Opinion on Drug Safety|June 22, 2017
Antiviral treatment of hepatitis C in renal transplant patients - safety issuesStella De Nicola, Massimo Colombo
Journal of Hepatology|December 23, 2018
The EASL International Liver Foundation: A growing pup with missions that are distinct yet integrated with those of its motherMassimo Colombo, Tom Hemming Karlsen
Gastroenterology|September 21, 2014
Prophylaxis of rebleeding in hepatocellular carcinoma: pushing the envelope or a real clinical benefit?Vincenzo La Mura, Massimo Colombo
Pageof 38

Showing results (71-80 of 372) with videos related to

Sort By:
Pageof 38
Gut|August 8, 2013
Treatment of patients with dual hepatitis B and C: a step in the right directionAlessio Aghemo, Massimo Colombo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 5, 2013
Safety of direct antiviral agents in real lifeRoberta D'Ambrosio, Massimo Colombo
Seminars in Immunopathology|September 27, 2012
Hepatocellular carcinoma in chronic hepatitis C: from bench to bedsideAlessio Aghemo, Massimo Colombo
Hepatic Oncology|October 11, 2018
The impact of antiviral therapy on hepatocellular carcinoma epidemiologyMassimo Colombo, Ana Lleo
Seminars in Liver Disease|March 5, 2013
Shaping the future management of hepatocellular carcinomaGhassan Abou-Alfa, Massimo Colombo
Gastroenterology|May 29, 2014
Bacterial translocation and nonselective β-blockers in portal hypertension: where we are, what we still needVincenzo La Mura, Massimo Colombo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2014
Entering a new era in the treatment of hepatitis CMassimo Colombo, Markus Peck-Radosavljevic
Expert Opinion on Drug Safety|June 22, 2017
Antiviral treatment of hepatitis C in renal transplant patients - safety issuesStella De Nicola, Massimo Colombo
Journal of Hepatology|December 23, 2018
The EASL International Liver Foundation: A growing pup with missions that are distinct yet integrated with those of its motherMassimo Colombo, Tom Hemming Karlsen
Gastroenterology|September 21, 2014
Prophylaxis of rebleeding in hepatocellular carcinoma: pushing the envelope or a real clinical benefit?Vincenzo La Mura, Massimo Colombo
Pageof 38